Stay updated on Tucatinib Combo Efficacy in HER2+ Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Tucatinib Combo Efficacy in HER2+ Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Tucatinib Combo Efficacy in HER2+ Breast Cancer Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.
    Difference
    0.3%
    Check dated 2025-04-30T13:58:25.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The date has been updated from February 19, 2025, to April 18, 2025.
    Difference
    0.6%
    Check dated 2025-04-23T08:37:20.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    The web page has been updated to version 2.15.0, replacing the previous version 2.14.4.
    Difference
    1.0%
    Check dated 2025-04-16T02:13:48.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The web page has updated its version from v2.14.3 to v2.14.4, and a date has been added for February 19, 2025, while a date for March 25, 2025, has been removed.
    Difference
    1.0%
    Check dated 2025-04-08T23:51:27.000Z thumbnail image
  6. Check
    73 days ago
    Change Detected
    Summary
    The page now includes updated information about Seagen, a subsidiary of Pfizer, and a new date of February 19, 2025, while the previous date of February 3, 2025, has been removed.
    Difference
    8%
    Check dated 2025-02-24T19:06:38.000Z thumbnail image
  7. Check
    87 days ago
    Change Detected
    Summary
    The webpage now includes a notice about heavy traffic affecting NLM-NCBI services and products, along with a contact for assistance. Additionally, a date has been updated from September 4, 2024, to February 3, 2025.
    Difference
    7%
    Check dated 2025-02-10T09:24:07.000Z thumbnail image

Stay in the know with updates to Tucatinib Combo Efficacy in HER2+ Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Tucatinib Combo Efficacy in HER2+ Breast Cancer Clinical Trial page.